BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+16.43%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.58B
AUM Growth
+$403M
(+34%)
Cap. Flow
+$233M
Cap. Flow
% of AUM
14.78%
Top 10 Holdings %
Top 10 Hldgs %
32.67%
Holding
149
New
11
Increased
79
Reduced
34
Closed
11
Top Buys
| 1 |
Abbott
ABT
|
$14.5M |
| 2 |
Pacific Biosciences
PACB
|
$13.9M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$10.2M |
| 4 |
CareDx
CDNA
|
$9.72M |
| 5 |
Medtronic
MDT
|
$9.3M |
Top Sells
| 1 |
DexCom
DXCM
|
$28.5M |
| 2 |
Bausch Health
BHC
|
$3.02M |
| 3 |
Amgen
AMGN
|
$2.27M |
| 4 |
Gilead Sciences
GILD
|
$1.76M |
| 5 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$1.67M |
Sector Composition
| 1 | Healthcare | 93.18% |
| 2 | Industrials | 1.09% |
| 3 | Technology | 0.34% |
| 4 | Financials | 0.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRAH
26
DELISTED
PRA Health Sciences, Inc.
PRAH
| $18.3M | 1.16% |
166,400
+37,000
| +29% | +$4.08M |
|
|
WMGI
27
DELISTED
Wright Medical Group Inc
WMGI
| $18.1M | 1.15% |
622,692
+52,391
| +9% | +$1.52M |
|
|
HRC
28
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $17.5M | 1.11% |
185,689
+6,000
| +3% | +$566K |
|
29
Esperion Therapeutics
ESPR
$490M
| $17.4M | 1.1% |
391,852
+78,332
| +25% | +$3.48M |
|
|
WBA
30
DELISTED
Walgreens Boots Alliance
WBA
| $16.5M | 1.05% |
226,018
| – | – |
|
31
Labcorp
LH
$22.8B
| $16.3M | 1.04% |
109,463
+21,884
| +25% | +$3.27M |
|
32
Ionis Pharmaceuticals
IONS
$9.64B
| $16M | 1.02% |
310,536
-12,050
| -4% | -$622K |
|
33
MacroGenics
MGNX
$121M
| $15.5M | 0.99% |
724,302
+127,389
| +21% | +$2.73M |
|
|
KTWO
34
DELISTED
K2M Group Holdings, Inc
KTWO
| $15.1M | 0.96% |
552,054
-60,887
| -10% | -$1.67M |
|
|
ALDR
35
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $15.1M | 0.96% |
905,254
+146,290
| +19% | +$2.44M |
|
|
ABMD
36
DELISTED
Abiomed Inc
ABMD
| $14.9M | 0.95% |
33,135
+6,054
| +22% | +$2.72M |
|
37
Hologic
HOLX
$14.7B
| $14.8M | 0.94% |
361,894
| – | – |
|
|
AKCA
38
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $14.7M | 0.93% |
418,496
+39,195
| +10% | +$1.37M |
|
39
LivaNova
LIVN
$3.09B
| $14.4M | 0.92% |
116,443
+6,519
| +6% | +$808K |
|
|
40
Pacific Biosciences
PACB
$378M
| $13.9M | 0.88% |
+2,575,000
| New | +$13.9M |
|
41
Biogen
BIIB
$20.5B
| $13.9M | 0.88% |
39,245
-100
| -0.3% | -$35.3K |
|
|
FIT
42
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $13.4M | 0.85% |
2,513,900
+456,000
| +22% | +$2.44M |
|
43
HUTCHMED
HCM
$2.62B
| $12.9M | 0.82% |
400,029
+67,493
| +20% | +$2.17M |
|
44
Zimmer Biomet
ZBH
$20.8B
| $12.1M | 0.77% |
94,867
+21,324
| +29% | +$2.72M |
|
|
SHPG
45
DELISTED
Shire pic
SHPG
| $11.6M | 0.74% |
64,185
-1,107
| -2% | -$201K |
|
46
Insmed
INSM
$30.3B
| $11.5M | 0.73% |
566,301
+142,250
| +34% | +$2.88M |
|
47
ResMed
RMD
$39.4B
| $10.7M | 0.68% |
93,192
+10,992
| +13% | +$1.27M |
|
|
48
Gilead Sciences
GILD
$140B
| $10.6M | 0.67% |
137,500
-22,800
| -14% | -$1.76M |
|
49
Regeneron Pharmaceuticals
REGN
$59.8B
| $10.3M | 0.65% |
25,480
+8,220
| +48% | +$3.32M |
|
|
50
DexCom
DXCM
$30.9B
| $10.2M | 0.65% |
286,588
-797,000
| -74% | -$28.5M |
|